Stanford Autonomic Disorders Program Clinical Trials

Natural History Study of Synucleinopathies
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Jordan Seliger
Contact:  jseliger@stanford.edu

A novel noninvasive thermoregulatory device for postural tachycardia syndrome
PI: Mitchell Miglis, MD
Study Status: Closed to enrollment
Research Coordinator: Jordan Seliger
Contact:  jseliger@stanford.edu

Autonomic Complications of Post-Acute COVID Syndrome
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Jordan Seliger or Adele Viviani
Contact:  jseliger@stanford.edu or aviviani@stanford.edu

A phase 2 randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of efgartigimod IV in adult patients with post–COVID-19 postural orthostatic tachycardia syndrome (POTS)
PI: Mitchell Miglis, MD
Study Status: Closed to enrollment
Research Coordinator: Jannika Machnik
Contact:  jmachnik@stanford.edu

Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of Efgartigimod in Adult Patients with Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) who Completed Study ARGX-113-2104
PI: Mitchell Miglis, MD
Study Status: Closed to enrollment
Research Coordinator: Jannika Machnik
Contact:  jmachnik@stanford.edu

TTR Amyloidosis Prevalence And Phenotype (TTRAPP Study)
PI: Safwan Jaradeh, MD
Study Status: Open to enrollment
Research Coordinator: Jannika Machnik
Contact:  jmachnik@stanford.edu

North American Prodromal Synucleinopathy Stage 2 (NAPS2) Consortium
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Adele Viviani
Contact: aviviani@stanford.edu

Autonomic Complications of PASC (RECOVER)
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Adele Viviani
Contact: aviviani@stanford.edu

Open-label prospective study for immune therapies in autoimmune gastrointestinal dysmotility (AGID)
PI: Dong-In Sinn, MD
Study Status: Open to enrollment
Research Coordinator: Jannika Machnik or Jordan Seliger
Contact:  jmachnik@stanford.edu or jseliger@stanford.edu

A Phase 3, Multi-center, Randomized Withdrawal and Long-Term Extension Study of Ampreloxetine for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Participants with Multiple System Atrophy
PI: Dong-In Sinn, MD
Study Status: Open to enrollment
Research Coordinator: Jordan Seliger or Adele Viviani
Contact:  jseliger@stanford.edu or aviviani@stanford.edu

Syn-Sleep Study
PI: Mitchell Miglis, MD
Study Status: Open to enrollment
Research Coordinator: Adele Viviani
Contact: aviviani@stanford.edu

A Phase 2, double-blind, placebo-controlled, parallel-group study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and potential efficacy of multiple doses of ONO-2808 in patients with Multiple System Atrophy (MSA)
PI: Mitchell Miglis, MD
Study Status: Enrolling Soon
Research Coordinator: Jordan Seliger or Adele Viviani
Contact:  jseliger@stanford.edu or aviviani@stanford.edu